Developing essential medicines

ath_who1

29 medicines developed by Roche are included in the WHO Model Lists of Essential Medicines. Twenty-five of these are patent-free and include life-saving antibiotics, anti-malarials and chemotherapy.

The WHO core list contains medicines believed to be required for a basic healthcare system, including the most efficacious, safe and cost effective medicines for priority conditions. The WHO Model List serves as a guide for the development of national and institutional essential medicine lists.

Roche products on the WHO Model List of Essential Medicines (2016)
Product Treatment area
amitriptyline (Laroxyl) Anti-depressant / Pallative care
ascorbic acid (Redoxon) Vitamin C deficiency
benznidazole (Radanil, Rochagan) American trypanosomiasis (Chagas disease)
capecitabine (Xeloda) Breast, colon and rectal cancer
ceftriaxone (Rocephin) Broad-spectrum cephalosporin antibiotic
cycloserine (D-Cycloserine) Pulmonary tuberculosis
diazepam (Valium) Tranquilizer
flucytosine (Ancotil) Antifungal medicine
fluorouracil (Fluorouracil) Chemotherapeutic agent
heparin sodium (Liquemin) Anti-coagulation agent
isoniazid (Rimifon) Tuberculosis
levodopa + benserazide (Madopar) Parkinson's disease
mefloquine (Lariam) Malaria
midazolam (Dormicum) Sedation/ Palliative care
neostigmine (Prostigmin) Myasthenia gravis/ Anaesthesia
oseltamivir (Tamiflu) Anti-viral/ Influenza
pegylated interferon alpha 2a or 2b (Pegasys) Anti-viral/ Hepatitis C
phytomenadione (Konakion) Anti-coagulation agent
procarbazine (Natulan) Hodgkin's lymphoma
protamine hydrochloride (Protamin) Heparin antagonist
pyridostigmine (Mestinon) Myasthenia gravis
retinol (Arovit) Vitamin A deficiency
rituximab (MabThera) Non Hodgkin's lymphoma, chronic lymphocytic leukemia
saquinavir (Invirase) HIV/AIDS
sulfadoxine + pyrimethamine (Fansidar) Malaria
sulfamethoxazole + trimethoprim / co-trimoxazole (Bactrim) Anti-bacterial agent
thiamine (Berolase) Heart failure/Vitamin B1 deficiency
trastuzumab (Herceptin) Breast cancer
valganciclovir (Valcyte) Cytomegalovirus

For more information see: www.who.int/medicines/publications/essentialmedicines/en

More stories

All

Tags: Access to healthcare